Bruker Corporation (BRKR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Bruker Corporation (BRKR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha9/22/2026Neutral
BRKR
Bruker CorporationNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$9.78B
P/E Ratio
—
EPS
$-0.75
Beta
1.26
52W High
$65.26
52W Low
$29.96
50-Day MA
$58.38
200-Day MA
$48.77
Dividend Yield
0.31%
Profit Margin
-2.04%
Forward P/E
13.83
PEG Ratio
1.52
About Bruker Corporation
Bruker Corporation develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions in the United States, Europe, Asia Pacific, and internationally. The company is headquartered in Billerica, Massachusetts.
Fundamentals
| Revenue (TTM) | $3.50B |
| Gross Profit (TTM) | $1.70B |
| EBITDA | $541.10M |
| Operating Margin | 9.88% |
| Return on Equity | -3.00% |
| Return on Assets | 3.14% |
| Revenue/Share (TTM) | $23.01 |
| Book Value | $15.63 |
| Price-to-Book | 3.82 |
| Price-to-Sales (TTM) | 2.79 |
| EV/Revenue | 3.055 |
| EV/EBITDA | 39.72 |
| Quarterly Earnings Growth (YoY) | -81.80% |
| Quarterly Revenue Growth (YoY) | 5.20% |
| Shares Outstanding | $152.36M |
| Float | $103.69M |
| % Insiders | 26.97% |
| % Institutions | 95.82% |
Historical Volatility
HV 10-Day
64.88%
HV 20-Day
62.12%
HV 30-Day
54.46%
HV 60-Day
73.43%
HV Rank
56.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($60.00 target)
2
Strong Buy6
Buy4
Hold1
SellLatest News
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley
BERKELEY, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz–class instrumentation. These capabilities strengthen research in chemistry, materials science, structural biology, and related fields across UC Berkeley an.
Business Wire9/21/2026Neutral
Bruker Corporation (BRKR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Bruker Corporation (BRKR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha9/16/2026Neutral
Bruker Corporation (BRKR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Bruker Corporation (BRKR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha9/9/2026Neutral
Bruker Corporation to Present at Upcoming Investor Conferences
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Wells Fargo 21st Annual Healthcare Conference in Boston, MA Wednesday, September 9, 2026 at 8:00 a.m. Eastern Time Morgan Stanley 24th Annual Global Healthcare Conference in New York City Wednesday, September 16, 2026, at 10:45 a.m. Eastern Time Bank of America Global Healthcare Conference in London, UK Tuesday, September 22, 2026, at 6:45 a.
Business Wire9/8/2026Neutral
BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion
HANAU, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (Nasdaq: BRKR), and Luvata Materials & Solutions, a Business Unit of Luvata Group (LUVATA) today announced a strategic collaboration to support the rapidly growing demand for superconducting materials and technologies required by next-generation magnetic confinement fusion power demonstration plant projects worldwide.The BEST-LUVATA collaboration aims to further strengthen and e.
Business Wire9/4/2026Neutral
Why Is Bruker (BRKR) Up 12.5% Since Last Earnings Report?
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research9/3/2026Positive
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development
LEIDEN, The Netherlands--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The investment expands Bruker's post-genomic solutions for disease biology research, as well as for drug discovery and development into Microphysiological Systems (MPS), also referred to as New Approach Methodologies (NAMs), and based on human ph.
Business Wire8/10/2026Neutral
Bruker Corporation (BRKR) Q2 2026 Earnings Call Transcript
Bruker Corporation (BRKR) Q2 2026 Earnings Call Transcript
Seeking Alpha8/4/2026Neutral
Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Bruker (BRKR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research8/4/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BRKR and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/26/2026